Holmes Defends Theranos' 'Aggressive' IP Protection At Trial
By Dorothy Atkins ( December 7, 2021, 11:15 PM EST) -- Ex-Theranos CEO Elizabeth Holmes' cross-examination in her criminal fraud trial wrapped Tuesday, with Holmes conceding that she didn't tell investors Theranos was performing blood tests on modified third-party devices but defending that and other sometimes "aggressive" actions as necessary to protect the startup's trade secrets....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.